Search Results - "VELINOVA, M"

Structure and aggregation proclivity of C12E3 in aqueous solution by Zahariev, Ts, Ivanova, A., Velinova, M., Tadjer, A.

“…[Display omitted] ► Dodecyl(triethylene glycol) and its dimers are modeled by DFT and ONIOM in water. ► Single molecules and dimers are very flexible and allow…”
Get full text

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes by Oussoren, C, Velinova, M, Scherphof, G, van der Want, J.J, van Rooijen, N, Storm, G

“…The ability of clodronate-containing liposomes to deplete lymph nodes of macrophages was used as a tool to investigate the fate of liposomes in regional lymph…”
Get full text

Uptake of Long-Circulating Immunoliposomes, Directed Against Colon Adenocarcinoma Cells, by Liver Metastases of Colon Cancer by Kamps, Jan, Koning, Gerben, Velinova, Maria, Morselt, Henriëtte, Wilkens, Marga, Gorter, Arko, Donga, Jan, Scherphof, Gerrit

“…AbstractRadiolabeled ([3H]cholesteryloleyl ether) immunoliposomes directed against rat colon adenocarcinoma CC531 cells were prepared by random coupling of a…”
Get full text

Abstract P3-14-10: Proposed biosimilar pegfilgrastim LA-EP2006 shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects by Nakov, R, Gattu, S, Wang, J, Velinova, M, Skerjanec, A

“…Abstract Background: Granulocyte colony-stimulating factors such as filgrastim and its long-acting version pegfilgrastim are widely used to prevent neutropenia…”
Get full text

Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat by Daemen, T, Velinova, M, Regts, J, de Jager, M, Kalicharan, R, Donga, J, van der Want, J J L, Scherphof, G L

“…Liposomes with diameters of 200 to 400 nm containing phosphatidylserine (PS) or phosphatidylglycerol (PG) were injected intravenously into rats. Two hours…”
Get full text

New histochemical and ultrastructural observations on normal bovine tonsils by Velinova, M., Thielen, C., Mklot, F., Eicher, S., Heinen, E., Antoine, N., Donga, J.

“…Samples of normal bovine palatine tonsils were examined by light and electron microscopy. Like human tonsils, they were composed of crypts, subepithelial…”
Get full text

Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells by Koning, Gerben A., Morselt, Henriëtte W.M., Velinova, Maria J., Donga, Jan, Gorter, Arko, Allen, Theresa M., Zalipsky, Samuel, Kamps, Jan A.A.M., Scherphof, Gerrit L.

“…A monoclonal antibody against the rat colon carcinoma CC531 was covalently coupled to liposomes containing a dipalmitoylated derivative of the anticancer drug…”
Get full text

1815PRandomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references by Velinova, M, Bellon, A, Nakov, R, Schussler, S, Schier-Mumzhiu, S, Schelcher, C, Koch, S D, Skerjanec, A, Wang, J, Krendyukov, A, Otto, G P

“…Abstract Background The pharmacokinetic (PK)/pharmacodynamic (PD), safety and immunogenicity profiles of Sandoz biosimilar pegfilgrastim (Ziextenzo®) and EU…”
Get full text

1815P - Randomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references by Velinova, M., Bellon, A., Nakov, R., Schussler, S., Schier-Mumzhiu, S., Schelcher, C., Koch, S.D., Skerjanec, A., Wang, J., Krendyukov, A., Otto, G.P.

“…The pharmacokinetic (PK)/pharmacodynamic (PD), safety and immunogenicity profiles of Sandoz biosimilar pegfilgrastim (Ziextenzo®) and EU reference…”
Get full text

Randomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references by Velinova, M., Bellon, A., Nakov, R., Schussler, S., Schier-Mumzhiu, S., Schelcher, C., Koch, S.D., Skerjanec, A., Wang, J., Krendyukov, A., Otto, G.P.

Get full text

Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects by Shin, Donghoon, Kim, Younsoo, Go, Ahra, Velinova, Maria

“…SB4 is an etanercept biosimilar, approved by the European Commission (EC) and the US Food and Drug Administration (FDA) following a demonstration of equivalent…”
Get full text

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects by Schneider, Frank, Erisson, Lavi, Beygi, Hooman, Bradbury, Margaret, Cohen‐Barak, Orit, Grachev, Igor D., Guzy, Serge, Loupe, Pippa S., Levi, Micha, McDonald, Mirna, Savola, Juha‐Matti, Papapetropoulos, Spyros, Tracewell, William G., Velinova, Maria, Spiegelstein, Ofer

“…Aims SD‐1077, a selectively deuterated precursor of dopamine (DA) structurally related to L‐3,4‐dihydroxyphenylalanine (L‐DOPA), is under development for…”
Get full text

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection by Oussoren, C, Velinova, M, Scherphof, G, van der Want, J.J, van Rooijen, N, Storm, G

Get full text

A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults by Pierce, David, Corcoran, Mary, Velinova, Maria, Hossack, Stuart, Hoppenbrouwers, Mieke, Martin, Patrick

“…About 30% of patients with gastroesophageal reflux disease continue to experience symptoms despite treatment with proton pump inhibitors. The…”
Get full text

Ultrastructural Analysis of DNA Complexes During Transfection and Intracellular Transport by Cartier, Regis, Velinova, Maria, Lehman, Cathleen, Erdmann, Bettina, Reszka, Regina

“…We present a simple method based on transmission electron microscopy that allows investigation of the early steps of polyplex-mediated transfection without the…”
Get full text

Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity by Burger, Koert N.J, Staffhorst, Rutger W.H.M, de Vijlder, Hanke C, Velinova, Maria J, Bomans, Paul H, Frederik, Peter M, de Kruijff, Ben

“…Cisplatin is one of the most widely used agents in the treatment of solid tumors, but its clinical utility is limited by toxicity. The development of less…”
Get full text

Modulation of pharmacokinetic behavior of liposomes by Scherphof, Gerrit L., Velinova, Maria, Kamps, Jan, Donga, Jan, van der Want, Han, Kuipers, Folkert, Havekes, Louis, Daemen, Toos

“…The authors's recent work on matters pertinent to the in vivo processing of systemically administered liposomes is reviewed. Particular emphasis is given to…”
Get full text

Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats by Velinova, Maria, Read, Nicholas, Kirby, Christopher, Gregoriadis, Gregory

“…Multilamellar liposomes composed of equimolar egg phosphatidylcholine and cholesterol and containing carboxyfluorescein or colloidal gold were injected…”
Get full text

Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity by Velinova, Maria J, Staffhorst, Rutger W.H.M, Mulder, Willem J.M, Dries, Arno S, Jansen, Bart A.J, de Kruijff, Ben, de Kroon, Anton I.P.M

“…Cisplatin nanocapsules represent a novel lipid formulation of the anti-cancer drug cis-diamminedichloroplatinum(II) (cisplatin), in which nanoprecipitates of…”
Get full text

SERUM ENZYME ACTIVITIES IN PROGRESSIVE MUSCULAR DYSTROPHY TREATED WITN NIVALINE OR P-ACETYLAMINOBENZILIDENE-ISONICOTINOYL HYDRAZONE by POPOV, N, VELINOVA, M

Get more information